WuXi Biologics Wins Multiple Asia-Pacific Biopharma Awards
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two...
Tag : WuXi Biologics
WuXi Biologics Wins EcoVadis Platinum, Top 1% Globally
WuXi Biologics (2269.HK), announced it has been awarded a Platinum Medal by the EcoVadis Sustainability Rating, marking the third year the company has received the rating’s...
WuXi Biologics, Vertex Sign License for T-cell Engager
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service...
WuXi Biologics Wins Hong Kong ESG Reporting Award
WuXi Biologics (2269.HK) has once again raised the bar for sustainability commitment and transparency. The company has been honored by the Hong Kong ESG Reporting Awards...
WuXi Biologics Completes First PPQ Campaign at 15,000L Line
The campaign marks the successful commercial-scale PPQ completion of Asia’s first 3 X 5,000L single-use bioreactorsProprietary process innovation reduces protein cost by nearly 70% while boosting yield...